# FDA Inspection 1106116 - Biomat USA, Inc. - August 23, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7c4c462e-002e-40a5-938d-e199514ffa79
Source feed: FDA_Inspections

> FDA Inspection 1106116 for Biomat USA, Inc. on August 23, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106116
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 987374 - 2016-07-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/636edbce-1706-4731-a5c9-6b218c5ee9b0)
- [FDA Inspection 797005 - 2012-08-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4b34f12f-c986-42e0-b383-43fabb9b57fb)

Company: https://www.keypedia.com/companies/biomat-usa-inc/7443b67e-d962-4574-bf89-b1d8241ed78d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d